[MeMed in Business Wire] MeMed Expands Advisory Board with Key Leaders to Advance Host-Response Diagnostics for Sepsis and AMR

ANDOVER, Mass. & HAIFA, Israel–(BUSINESS WIRE)–MeMed, a leader in host-response diagnostics, today announced the addition of three distinguished experts to its advisory board to accelerate its mission of addressing the global challenges of sepsis and antimicrobial resistance (AMR) through innovative diagnostic solutions.

Read more here.